Two giants of commercial gene research, Celera Genomics of Rockville,
Maryland, and Geron of Menlo Park, California, signed a deal this week to work
towards growing brand new organs from a patient’s own cells. Geron has a unique
supply of human stem cells, which can theoretically grow into particular sorts
of tissue, while sequencing heavyweight Celera will identify genes which control
tissue formation in embryos. “Our work under this alliance will bring us one
step closer to realising the therapeutic potential of human stem cells,” says
Thomas Okarma, Geron’s president.
To continue reading, today with our introductory offers
Advertisement
More from ¿ìè¶ÌÊÓƵ
Explore the latest news, articles and features
Popular articles
Trending ¿ìè¶ÌÊÓƵ articles
1
The best new science-fiction books of June 2026
2
Pancreatic cancer halted by virus injection in three patients
3
Does gravity create reality? A shocking path to a theory of everything
4
Aim high but don't shoot for the moon, mathematicians advise
5
Photons behave very strangely if you try to cut them
6
Glaciers in the 'roof of the world' have suddenly started melting
7
Mathematical AI helps researchers crack 50-year-old problem
8
How a radical new view of life could reveal its origin – and aliens
9
Wealthy people with environmental ideals are the biggest emitters
10
QBox theory may offer glimpse of reality deeper than quantum realm
